BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+9.68%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$2.59T
AUM Growth
+$221B
(+9.3%)
Cap. Flow
+$26.4B
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
15.55%
Holding
5,115
New
132
Increased
2,877
Reduced
1,441
Closed
133
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$3.04B |
| 2 |
Alibaba
BABA
|
+$2.48B |
| 3 |
Truist Financial
TFC
|
+$2.25B |
| 4 |
ServiceNow
NOW
|
+$889M |
| 5 |
iShares MBS ETF
MBB
|
+$841M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.03B |
| 4 |
Apple
AAPL
|
+$711M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
Sector Composition
| 1 | Technology | 18.32% |
| 2 | Financials | 14.51% |
| 3 | Healthcare | 13.67% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4001
CervoMed
CRVO
$82.8M
| $378K | ﹤0.01% |
+10,944
| New | +$378K |
|
4002
TIM SA
TIMB
$10B
| $375K | ﹤0.01% |
19,601
-80,684
| -80% | -$1.54M |
|
|
NBSE
4003
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $375K | ﹤0.01% |
2,603
+1,565
| +151% | +$225K |
|
4004
Sensus Healthcare
SRTS
$52.6M
| $375K | ﹤0.01% |
105,899
+712
| +0.7% | +$2.52K |
|
4005
Jakks Pacific
JAKK
$195M
| $374K | ﹤0.01% |
36,312
+26
| +0.1% | +$268 |
|
|
PBBI
4006
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
| $374K | ﹤0.01% |
24,705
-258
| -1% | -$3.91K |
|
4007
Cidara Therapeutics
CDTX
$1.61B
| $370K | ﹤0.01% |
4,821
-6,972
| -59% | -$535K |
|
4008
Vanguard Tax-Exempt Bond Index Fund
VTEB
$38.8B
| $370K | ﹤0.01% |
6,919
+2,041
| +42% | +$109K |
|
4009
Oragenics
OGEN
$4.75M
| $369K | ﹤0.01% |
392
| – | – |
|
|
ENT
4010
DELISTED
Global Eagle Entertainment Inc.
ENT
| $369K | ﹤0.01% |
29,536
+26
| +0.1% | +$325 |
|
4011
BioNTech
BNTX
$25.1B
| $368K | ﹤0.01% |
+10,872
| New | +$368K |
|
4012
Federal Agricultural Mortgage Class A
AGM.A
$1.52B
| $364K | ﹤0.01% |
4,949
+129
| +3% | +$9.49K |
|
|
GMO
4013
DELISTED
General Moly, Inc.
GMO
| $360K | ﹤0.01% |
1,586,736
+1,419
| +0.1% | +$322 |
|
4014
Intellicheck
IDN
$108M
| $359K | ﹤0.01% |
48,019
-303
| -0.6% | -$2.27K |
|
4015
Plumas Bancorp
PLBC
$313M
| $358K | ﹤0.01% |
13,572
-3,332
| -20% | -$87.9K |
|
4016
Smith & Nephew
SNN
$16.7B
| $356K | ﹤0.01% |
7,405
-11,209
| -60% | -$539K |
|
4017
Cogent Biosciences
COGT
$1.79B
| $355K | ﹤0.01% |
122,972
-36,819
| -23% | -$106K |
|
|
SVBI
4018
DELISTED
Severn Bancorp Inc/MD
SVBI
| $354K | ﹤0.01% |
38,049
+1,505
| +4% | +$14K |
|
|
TLGT
4019
DELISTED
Teligent, Inc
TLGT
| $352K | ﹤0.01% |
82,573
+90
| +0.1% | +$384 |
|
|
ALNA
4020
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $350K | ﹤0.01% |
128,254
-25,762
| -17% | -$70.3K |
|
4021
Astrotech Corp
ASTC
$8.42M
| $345K | ﹤0.01% |
6,389
| – | – |
|
4022
SPDR Dow Jones International Real Estate ETF
RWX
$309M
| $344K | ﹤0.01% |
8,868
-6,531
| -42% | -$253K |
|
4023
Lendway
LDWY
$9.29M
| $342K | ﹤0.01% |
66,919
+18
| +0% | +$92 |
|
|
FSTX
4024
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $340K | ﹤0.01% |
53,779
+1,573
| +3% | +$9.95K |
|
|
NOVN
4025
DELISTED
Novan, Inc. Common Stock
NOVN
| $339K | ﹤0.01% |
10,706
+1,397
| +15% | +$44.2K |
|